Histological protection by donepezil against neurodegeneration induced by ischemia-reperfusion in the rat retina

Journal of Pharmacological Sciences

Volumn 112, Issue 3, 2010, Pages 327-335

  Sakamoto, Kenji ^a   Ohki, Kayo ^a   Saito, Maki ^a   Nakahara, Tsutomu ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Acetylcholine esterase; Donepezil; Ischemia; Reperfusion; Retina

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINERGIC RECEPTOR; DONEPEZIL; MECAMYLAMINE; NEOSTIGMINE; NICOTINE; PILOCARPINE; SCOPOLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HISTOPATHOLOGY; MALE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION INJURY; RETINA BIPOLAR GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINA ISCHEMIA;

EID: 77950672003     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09302FP     Document Type: Article

References (39)

1. Louzada-Júnior P, Dias JJ, Santos WF, Lachat JJ, Bradford HF, Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem. 1992;59:358-363.
2. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 1995;18:58-60.
3. Dreyer EB. A proposed role for excitotoxicity in glaucoma. J Glaucoma. 1998;7:62-67.
4. Aizenman E, Frosch MP, Lipton SA. Responses mediated by excitatory amino acid receptors in solitary retinal ganglion cells from rat. J Physiol. 1988;396:75-91.
5. Yang XL. Characterization of receptors for glutamate and GABA in retinal neurons. Prog Neurobiol. 2004;73:127-150.
6. David P, Lusky M, Teichberg VI. Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp Eye Res. 1988;46:657-662.
7. Choi DW. Ionic dependence of glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7:369-379.
8. Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 1988;11:465-469.
9. Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am. 2005;18:383-395.
10. Siliprandi R, Canella R, Carmignoto G, Schiavo N, Zanellato A, Zanoni R, et al. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992;8:567-573.
11. Adachi K, Fujita Y, Morizane C, Akaike A, Ueda M, Satoh M, et al. Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina. Eur J Pharmacol. 1998;350: 53-57.
12. Rogers SL, Friedhoff LT. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol. 1998;8:67-75.
13. Zhou J, Fu Y, Tang XC. Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation. Neurosci Lett. 2001;306:53-56.
14. Kimura M, Komatsu H, Ogura H, Sawada K. Comparison of donepezil and memantine for protective effect against amyloidbeta(1-42) toxicity in rat septal neurons. Neurosci Lett. 2005;391: 17-21.
15. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci. 2002;43:1077-1087.
16. Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol. 2002;133:135-137.
17. Miki A, Otori Y, Morimoto T, Okada M, Tano Y. Protective effect of donepezil on retinal ganglion cells in vitro and in vivo. Curr Eye Res. 2006;31:69-77.
18. Sakamoto K, Kuwagata M, Nakahara T, Ishii K. Late preconditioning in rat retina: involvement of adenosine and ATP-sensitive K + channel. Eur J Pharmacol. 2001;418:89-93.
19. Sakamoto K, Yonoki Y, Kuwagata M, Saito M, Nakahara T, Ishii K. Histological protection against ischemia-reperfusion injury by early ischemic preconditioning in rat retina. Brain Res. 2004; 1015:154-160.
20. Sakamoto K, Yonoki Y, Kubota Y, Kuwagata M, Saito M, Nakahara T, et al. Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina. Exp Eye Res. 2006;82:512-518.
21. Sakamoto K, Kawakami T, Shimada M, Yamaguchi A, Kuwagata M, Saito M, et al. Histological protection by cilnidipine, a dual L/N-type Ca2+ channel blocker, against neurotoxicity induced by ischemia-reperfusion in rat retina. Exp Eye Res. 2009;88:974-982.
22. Giacobini E, Zhu XD, Williams E, Sherman KA. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex. Neuropharmacology. 1996;35:205-211.
23. Hejmadi MV, Dajas-Bailador F, Barns SM, Jones B, Wonnacott S. Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. Mol Cell Neurosci. 2003;24: 779-786.
24. Yasuyoshi H, Kashii S, Kikuchi M, Zhang S, Honda Y, Akaike A. New insight into the functional role of acetylcholine in developing embryonic rat retinal neurons. Invest Ophthalmol Vis Sci. 2002;43:446-451.
25. Wehrwein E, Thompson SA, Coulibaly SF, Linn DM, Linn CL. Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity. Invest Ophthalmol Vis Sci. 2004;45:1531-1543.
26. Pereira SP, Medina SV, Araujo EG. Cholinergic activity modulates the survival of retinal ganglion cells in culture: the role of M1 muscarinic receptors. Int J Dev Neurosci. 2001;19:559-567.
27. Fujiki M, Kobayashi H, Uchida S, Inoue R, Ishii K. Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats. Brain Res. 2005;1043:236-241.
28. Hutchins JB. Acetylcholine as a neurotransmitter in the vertebrate retina. Exp Eye Res. 1987;45:1-38.
29. Dawson GR, Iversen SD. The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behav Brain Res. 1993;57: 143-153.
30. Clayton BA, Hayashida K, Childers SR, Xiao R, Eisenach JC. Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism. Anesthesiology. 2007; 106:1019-1025.
31. Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, et al. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther. 2003; 306:772-777.
32. Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, Fujii T, et al. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. J Neurosci Res. 2008; 86:3575-3583.
33. Dureau P, Bonnel S, Menasche M, Dufier JL. Abitbol M. Quantitative analysis of intravitreal injections in the rat. Curr Eye Res. 2001;22:74-77.
34. Wang XD, Chen XQ, Yang HH, Hu GY. Comparison of the effects of cholinesterase inhibitors on [3 H]MK-801 binding in rat cerebral cortex. Neurosci Lett. 1999;272:21-24.
35. Li W, Pi R, Chan HH, Fu H, Lee NT, Tsang HW, et al. Novel dimeric acetylcholinesterase inhibitor bis(7)-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors. J Biol Chem. 2005;280: 18179-18188.
36. Saxena G, Singh SP, Agrawal R, Nath C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol. 2008;581:283-289.
37. Dunn NR, Pearce GL, Shakir SA. Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol. 2000;14:406-408.
38. Matsui K, Kagei Y, Mizuo H, Mishima M, Tadano K, Yoshimura T, et al. Absorption, distribution, metabolism and excretion of 14 C-donepezil hydrochloride after a single oral administration to rats. Jpn Pharmacol Ther. 1998;26 Suppl:1339-1355.
39. Eisai Co., Ltd. and Pfizer Inc. [Drug interview form of Aricept ® (donepezil hydrochloride).] 2000; p. 40. (in Japanese)